SYDNEY, Australia, April 13, 2023 (GLOBE NEWSWIRE) — Novotech, the leading biotech CRO based in Asia Pacific, meets with leading oncologists at the eChinaHealth discussion session and dinner at the AACR. The discussion will focus on the collaborative experience with China’s cancer research sector. (To register Here)

The panel discussion is part of the AACR Annual Meeting April 14-19, 2023 at the Orange County Convention Center, Orlando, Florida.

Meet the Novotech team that will be attending the AACR, including:

• Aditya Kotta, Regional Director Business Development US West Coast
• Steve Brandao, US East Coast Regional Manager Business Development Eduardo Aponte, Business Development Manager

Novotech sponsors the eChina Health China Dinner and Panel Discussion.

The panel discussion is titled China @ AACR and will focus on China’s international collaboration in cancer research. Each panelist will share their experiences of collaborating with China’s cancer research and clinical trials sector.

Session moderator:

• dr Shi-Yong Sun, President of the US-China Anti-Cancer Association (USCACA)
  

Panelist:

• dr David Carbone, director of the James Thoracic Oncology Center at OSUMC
• dr Roy Herbst, Yale Comprehensive Cancer Center, Yale School of Medicine
• Aditya Kotta, Regional Manager Business Development, Novotech
• Frédéric Biemar, PhD​, Director, International Affairs of AACR

to register Here
Monday 17 April 2023
agenda
6:30pm – 9:00pm EDT: Buffet Dinner & Social
6:45-7:15 p.m. EDT: Panelist Session (fireside chat)

Asia Pacific has seen 100% growth in oncology trials from 2017 to 2021 and contributes to more than a third of global clinical development of immuno-oncology drugs.

“By the end of 2021, 40% of active immuno-oncology clinical trials involved at least one site in Asia-Pacific, with the majority of trials conducted in China, followed by Australia, South Korea, Japan and Taiwan,” according to GlobaData.

The latest data shows that Asia-Pacific is also the…